Madrigal Drug Patent Portfolio

Madrigal owns 1 orange book drug protected by 5 US patents Given below is the list of Madrigal's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10376517 Methods of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
Active
US11564926 Methods of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
Active
US11986481 Method of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
Active
US9266861 Method of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
Active
US7452882 Thyroid hormone analogs 12 Sep, 2026
Active


Given below is the list of recent legal activities going on the following drug patents of Madrigal.

Activity Date Patent Number
Patent litigations
Change in Power of Attorney (May Include Associate POA) 26 Jun, 2024 US7452882
Email Notification 26 Jun, 2024 US7452882
Initial letter Re: PTE Application to regulating agency 07 May, 2024 US9266861
Initial letter Re: PTE Application to regulating agency 07 May, 2024 US7452882
Requirement for information sent under 37 CFR 1.750 07 May, 2024 US7452882
Patent Term Extension Application under 35 USC 156 Filed 02 May, 2024 US7452882
Patent Term Extension Application under 35 USC 156 Filed 02 May, 2024 US9266861
Email Notification 17 Apr, 2024 US7452882
Change in Power of Attorney (May Include Associate POA) 17 Apr, 2024 US7452882
Change in Power of Attorney (May Include Associate POA) 11 Apr, 2024 US9266861
Email Notification 11 Apr, 2024 US9266861
7.5 yr surcharge - late pmt w/in 6 mo, Large Entity 29 Aug, 2023 US9266861
Payment of Maintenance Fee, 8th Year, Large Entity 29 Aug, 2023 US9266861
Payment of Maintenance Fee, 4th Year, Large Entity 13 Feb, 2023 US10376517
Patent Issue Date Used in PTA Calculation 31 Jan, 2023 US11564926


Madrigal's Family Patents


Family Patents



Madrigal Drug List

Given below is the complete list of Madrigal's drugs and the patents protecting them.


1. Rezdiffra

Rezdiffra is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10376517 Methods of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
(8 years from now)
Active
US11564926 Methods of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
(8 years from now)
Active
US11986481 Method of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
(8 years from now)
Active
US9266861 Method of synthesizing thyroid hormone analogs and polymorphs thereof 17 Sep, 2033
(8 years from now)
Active
US7452882 Thyroid hormone analogs 12 Sep, 2026
(1 year, 10 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rezdiffra's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Madrigal News

Considering Investing in Madrigal Pharmaceuticals? Eli Lilly Wants to Discuss.

16 Jun, 2024

Reasons for the Surge in Madrigal Pharmaceuticals' Stock Today

10 Jun, 2024

See More